Pemberdayaan Masyarakat Berbantuan AI untuk Pengawasan Obat dan Makanan Berbasis Risiko di Pasar Digital
Original Full-Text Article
Download published version for reading and archivingAbstract
Trading through marketplaces expands public access to drugs and food, but it also increases the complexity of oversight because of the large volume of products, sellers, and digital information. This study aims to formulate an artificial intelligence (AI)-supported public participation model that strengthens risk-based drug and food oversight while maintaining the accountability of human regulators. The study employed a normative juridical method with statutory and conceptual approaches, supported by a review of previous research on digital public participation, artificial intelligence, risk-based oversight, and algorithmic accountability. The study produced the AI-Assisted Public Participation Model (AIPPM), which integrates public reporting, AI-based screening, risk prioritization, regulator verification, oversight action, and public feedback. The model positions the public as a source of regulatory intelligence, AI as an instrument that supports risk detection and prioritization, and human regulators as the final decision-makers. This integration has the potential to improve the reach, speed, and accuracy of oversight priorities in digital commerce without transferring regulatory authority and responsibility to algorithms, in line with the principle “AI detects and prioritizes; humans verify and decide”.
Keywords:
Author Biographies
Badan Pengawas Obat dan Makanan, Kota Jakarta Pusat, Daerah Khusus Ibukota Jakarta, Indonesia
How to Cite
This work is licensed under a Copyright (c) 2026 Ardianto Nugroho .
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License .
- Share: You are free to copy, distribute, and transmit the work in any medium or format.
- Adapt: You are free to remix, transform, and build upon the work for any purpose, even commercially.
- Attribution: You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
References
Total: 21 References- Badan Pengawas Obat dan Makanan. (2024). Peraturan Badan Pengawas Obat dan Makanan Nomor 14 Tahun 2024 tentang pengawasan obat dan makanan yang diedarkan secara daring. https://peraturan.bpk.go.id/Details/297143/perka-bpom-
- Badan Pengawas Obat dan Makanan. (2025a). Peraturan Badan Pengawas Obat dan Makanan Nomor 16 Tahun 2025 tentang pengawasan sediaan farmasi dan pangan olahan melalui peran serta masyarakat. https://peraturan.go.id/id/peraturan-bpom-no-16-tahun-2025
- Badan Pengawas Obat dan Makanan. (2025b). Peraturan Badan Pengawas Obat dan Makanan Nomor 30 Tahun 2025 tentang perubahan atas Peraturan Badan Pengawas Obat dan Makanan Nomor 14 Tahun 2024 tentang pengawasan obat dan makanan yang diedarkan secara daring. https://peraturan.bpk.go.id/Details/335228/peraturan-bpom-no-30-tahun-2025
- Badan Pengawas Obat dan Makanan. (2026, March 5). Top 10 produk obat dan makanan ilegal atau berbahaya yang beredar di marketplace sepanjang tahun 2025 [Siaran pers]. https://www.pom.go.id/siaran-pers/top-10-produk-obat-dan-makanan-ilegal-atau-berbahaya-yang-beredar-di-marketplace-sepanjang-tahun-2025
- Busuioc, M. (2021). Accountable artificial intelligence: Holding algorithms to account. Public Administration Review, 81(5), 825–836. https://doi.org/10.1111/puar.13293